When tumor-associated fibroblasts (CAFs) secrete EVs containing miR-320a, miR-320a inhibits HCC growth by suppressing the PBX3/ERK1/2/CDK2 pathway in HCC cells (164). This evidence concerns the gene MAPK3 and neoplasm.